Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell
Castle Creek Pharmaceutical Holdings, Inc. announced it has reached an agreement to acquire Fibrocell Science, a cell and gene therapy company focused on transformational autologous…
Read More...
Read More...
